Breaking News Instant updates and real-time market news.

MYL

Mylan

$41.26

0.87 (2.15%)

, MKGAY

Merck KGaA

$38.36

(0.00%)

07:22
04/13/18
04/13
07:22
04/13/18
07:22

Mylan seeks deal for Merck's consumer products unit, Reuters reports

Mylan (MYL) is in advanced talks to acquire Merck KGaA's (MKGAY) consumer health division after other suitors failed to meet the company's price expectations, Reuters reports, citing people familiar with the matter. The companies are negotiating a price between EUR3.5B and EUR4B, or $4.3B-$4.9B, although there is no certainty Mylan, which has been in discussion with private equity groups on the asset, will secure a deal. Reference Link

MYL

Mylan

$41.26

0.87 (2.15%)

MKGAY

Merck KGaA

$38.36

(0.00%)

  • 27

    Apr

  • 18

    May

  • 13

    Nov

MYL Mylan
$41.26

0.87 (2.15%)

04/12/18
LEER
04/12/18
UPGRADE
LEER
Outperform
Mylan upgraded to Outperform from Market Perform at Leerink
04/12/18
04/12/18
UPGRADE
Target $52

Outperform
Mylan upgraded to Outperform at Leerink
As previously reported, Leerink analyst Ami Fadia upgraded Mylan to Outperform from Market Perform, with a $52 price target, citing valuation disconnect given the diversified business and catalyst path.
04/12/18
JPMS
04/12/18
NO CHANGE
Target $53
JPMS
Overweight
Mylan shares remain 'highly inexpensive,' says JPMorgan
JPMorgan analyst Chris Schott says his positive longer term thesis is unchanged following Mylan's investor day. Commentary on the near-term pipeline remained upbeat and Mylan highlighted multiple long-term revenue drivers, Schott tells investors in a research note. He believes the company's "significant" generic Advair opportunity, as well as other potential near-term approvals, more than offset any downside risk from ongoing challenges in the U.S. generics market. The analyst thinks Mylan shares remain "highly inexpensive." Schott keeps an Overweight rating on the name with a $53 price target.
04/12/18
04/12/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Incyte (INCY) upgraded to Buy from Neutral at UBS with analyst Carter Gould saying the stock offers an improved risk/reward profile after resetting lower on negative epacadostat Phase 3 data and removal of the drug from analyst models. 2. TechnipFMC (FTI) upgraded to Buy from Neutral at Goldman Sachs with analyst Waqar Syed saying while his 2018/2019 EBITDA estimates are little changed, his 2020 EBITDA estimates have been raised nearly 18% owing to expectations for higher inbound orders in 2019 for the Subsea and Onshore/Offshore segments. 3. Prologis (PLD) upgraded to Buy from Hold at Jefferies with analyst Jonathan Petersen saying he sees the company posting one of the strongest levels of internal growth among the blue-chip real estate investment trusts in 2018. 4. Mylan (MYL) upgraded to Outperform from Market Perform at Leerink with analyst Ami Fadia citing valuation disconnect given the diversified business and catalyst path. 5. Summit Hotel Properties (INN) upgraded to Buy from Underperform at BofA/Merrill with analyst Shaun Kelley citing relative valuation, its potential to outperform peers on the top-line in an accelerating RevPAR environment, and lower relative cost pressure given a lower proportion of labor costs. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
MKGAY Merck KGaA
$38.36

(0.00%)

TODAY'S FREE FLY STORIES

ADBE

Adobe

$238.05

-10.84 (-4.36%)

18:02
10/15/18
10/15
18:02
10/15/18
18:02
Hot Stocks
Adobe says it sees increased demand for PDF capabilities »

Says it has over 300,000…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

GOOG

Alphabet

$1,092.00

-18.93 (-1.70%)

, GOOGL

Alphabet Class A

$1,101.58

-19.41 (-1.73%)

18:02
10/15/18
10/15
18:02
10/15/18
18:02
Periodicals
Google's Greene will not attend Saudi Aarabia summit, Bloomberg says »

Diane Greene, who runs…

GOOG

Alphabet

$1,092.00

-18.93 (-1.70%)

GOOGL

Alphabet Class A

$1,101.58

-19.41 (-1.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 21

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 07

    Nov

  • 03

    Mar

CE

Celanese

$97.99

-0.685 (-0.69%)

18:01
10/15/18
10/15
18:01
10/15/18
18:01
Hot Stocks
Celanese unveils Customer Options Mapping approach to customer engagement »

Celanese announced its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

OII

Oceaneering

$25.69

0.4 (1.58%)

18:00
10/15/18
10/15
18:00
10/15/18
18:00
Hot Stocks
Oceaneering prepares for landfall of Hurricane Michael »

Oceaneering International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

OPGN

OpGen

$1.91

-0.01 (-0.52%)

17:57
10/15/18
10/15
17:57
10/15/18
17:57
Hot Stocks
OpGen selected to participate in AMR surveillance initiative during Q3 »

OpGen continues to make…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OPGN

OpGen

$1.91

-0.01 (-0.52%)

17:45
10/15/18
10/15
17:45
10/15/18
17:45
Earnings
OpGen says preliminary Q3 revenue $550K vs. $750K in Q317 »

Total preliminary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TPX

Tempur Sealy

$47.87

0.03 (0.06%)

, SHLD

Sears

$0.31

-0.0901 (-22.52%)

17:44
10/15/18
10/15
17:44
10/15/18
17:44
Hot Stocks
Tempur Sealy: Sears represented less than 5% of company's global net sales »

In connection with the…

TPX

Tempur Sealy

$47.87

0.03 (0.06%)

SHLD

Sears

$0.31

-0.0901 (-22.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLD

SPDR Gold Trust

$115.95

0.71 (0.62%)

17:42
10/15/18
10/15
17:42
10/15/18
17:42
Hot Stocks
SPDR Gold Trust rise to 748.76MT from 744.64MT »

This is the 2nd…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IGC

India Globalization Capital

$5.30

0.35 (7.07%)

17:35
10/15/18
10/15
17:35
10/15/18
17:35
Syndicate
Breaking Syndicate news story on India Globalization Capital »

India Globalization…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

RWLK

ReWalk Robotics

$0.81

-0.0038 (-0.47%)

17:34
10/15/18
10/15
17:34
10/15/18
17:34
Syndicate
Breaking Syndicate news story on ReWalk Robotics »

ReWalk Robotics files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZBH

Zimmer Biomet

$123.59

0.12 (0.10%)

17:34
10/15/18
10/15
17:34
10/15/18
17:34
Initiation
Zimmer Biomet initiated  »

Zimmer Biomet initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 26

    Oct

RIO

Rio Tinto

$49.54

0.34 (0.69%)

17:34
10/15/18
10/15
17:34
10/15/18
17:34
Hot Stocks
Breaking Hot Stocks news story on Rio Tinto »

Rio Tinto sees Pilbara…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TFX

Teleflex

$249.10

0.64 (0.26%)

17:33
10/15/18
10/15
17:33
10/15/18
17:33
Initiation
Teleflex initiated  »

Teleflex initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

RIO

Rio Tinto

$49.54

0.34 (0.69%)

17:33
10/15/18
10/15
17:33
10/15/18
17:33
Hot Stocks
Rio Tinto reports Q3 Pilbara iron ore output 82.5M tons, down 3% from last year »

Pilbara iron ore…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYK

Stryker

$169.42

-1.66 (-0.97%)

17:33
10/15/18
10/15
17:33
10/15/18
17:33
Initiation
Stryker initiated  »

Stryker initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

MDT

Medtronic

$93.81

-0.85 (-0.90%)

17:32
10/15/18
10/15
17:32
10/15/18
17:32
Initiation
Medtronic initiated  »

Medtronic initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$238.05

-10.84 (-4.36%)

17:31
10/15/18
10/15
17:31
10/15/18
17:31
Hot Stocks
Adobe says it is expanding creative cloud to non-professionals »

Says over the last few…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

HRC

Hill-Rom

$87.26

-1.04 (-1.18%)

17:30
10/15/18
10/15
17:30
10/15/18
17:30
Initiation
Hill-Rom initiated  »

Hill-Rom initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

EW

Edwards Lifesciences

$141.95

-1.44 (-1.00%)

17:29
10/15/18
10/15
17:29
10/15/18
17:29
Initiation
Edwards Lifesciences initiated  »

Edwards Lifesciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

CNMD

CONMED

$73.17

0.73 (1.01%)

17:28
10/15/18
10/15
17:28
10/15/18
17:28
Initiation
CONMED initiated  »

CONMED initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

TTOO

T2 Biosystems

$5.30

0.17 (3.31%)

17:27
10/15/18
10/15
17:27
10/15/18
17:27
Syndicate
Breaking Syndicate news story on T2 Biosystems »

T2 Biosystems files $100M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BSX

Boston Scientific

$36.43

-0.56 (-1.51%)

17:26
10/15/18
10/15
17:26
10/15/18
17:26
Initiation
Boston Scientific initiated  »

Boston Scientific…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

BDX

Becton Dickinson

$238.38

-4.33 (-1.78%)

17:25
10/15/18
10/15
17:25
10/15/18
17:25
Initiation
Becton Dickinson initiated  »

Becton Dickinson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

BAX

Baxter

$70.88

-0.39 (-0.55%)

17:24
10/15/18
10/15
17:24
10/15/18
17:24
Initiation
Baxter initiated  »

Baxter initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 23

    Oct

  • 31

    Oct

CRMD

CorMedix

$2.15

-0.12 (-5.29%)

17:23
10/15/18
10/15
17:23
10/15/18
17:23
Syndicate
Breaking Syndicate news story on CorMedix »

CorMedix files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.